MENU
AIDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

20/20 Biolabs (AIDX) Ownership - Who owns 20/20 Biolabs?

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility... Show more

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
6.44M
P/E Ratio
N/A
Total Cash
4.22M
Projected Growth
N/A
Total Debt
925.49K
Revenue
1.84M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.34
Total Debt/Equity
N/A
Revenue/Share
0.18 USD as % of share price
View a ticker or compare two or three
AIDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Details